2019 Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 60 pages | ID: 26B29AB36E2EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neuromyelitis Optica (Devic’s Syndrome). It presents in-depth analysis of Neuromyelitis Optica (Devic’s Syndrome) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Neuromyelitis Optica (Devic’s Syndrome).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Neuromyelitis Optica (Devic’s Syndrome) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Neuromyelitis Optica (Devic’s Syndrome)

The research work is prepared through extensive and continuous research on Neuromyelitis Optica (Devic’s Syndrome) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Neuromyelitis Optica (Devic’s Syndrome) patients are identified
• The report includes panorama of Neuromyelitis Optica (Devic’s Syndrome) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Neuromyelitis Optica (Devic’s Syndrome) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Region
  2.2.2 Average Enrollment of Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Neuromyelitis Optica (Devic’s Syndrome) Treatment, 2019

3. REGION WISE NEUROMYELITIS OPTICA (DEVIC’S SYNDROME) CLINICAL TRIALS

3.1 Asia Pacific Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Country
3.2 Europe Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Country
3.3 North America Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Country
3.4 Middle East and Africa Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Country
3.5 South and Central America Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Country

4. NEUROMYELITIS OPTICA (DEVIC’S SYNDROME) CLINICAL TRIAL TRENDS

4.1 Start Year wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials
4.2 Phase wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials
4.3 Trial Status wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials
4.4 Trial Type wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials

5. NEUROMYELITIS OPTICA (DEVIC’S SYNDROME) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Neuromyelitis Optica (Devic’s Syndrome) Trials by Year
5.2 Average Enrollment in Neuromyelitis Optica (Devic’s Syndrome) Trials by Phase
5.3 Average Enrollment in Neuromyelitis Optica (Devic’s Syndrome) Trials by Status
5.4 Average Enrollment in Neuromyelitis Optica (Devic’s Syndrome) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN NEUROMYELITIS OPTICA (DEVIC’S SYNDROME) CLINICAL TRIALS

6.1 Neuromyelitis Optica (Devic’s Syndrome) Trials by Sponsor Type
6.2 Neuromyelitis Optica (Devic’s Syndrome) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Neuromyelitis Optica (Devic’s Syndrome) Trials- Phase
7.2 Neuromyelitis Optica (Devic’s Syndrome) Trials- Phase
7.3 Neuromyelitis Optica (Devic’s Syndrome) Trials- Phase
7.4 Neuromyelitis Optica (Devic’s Syndrome) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials and Enrolment
Figure 7: North America – Country wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials and Enrolment
Figure 9: Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Phase
Figure 10: Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Trial Status
Figure 11: Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Type
Figure 12: Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Sponsor Type
Figure 13: Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials by Leading Sponsors
Figure 14: Neuromyelitis Optica (Devic’s Syndrome) Average Enrollment by Phase
Figure 15: Neuromyelitis Optica (Devic’s Syndrome) Average Enrollment by Trial Status
Figure 16: Neuromyelitis Optica (Devic’s Syndrome) Average Enrollment by Type
Figure 17: Neuromyelitis Optica (Devic’s Syndrome)- Average Enrolment by Type of Sponsors
Figure 18: Neuromyelitis Optica (Devic’s Syndrome)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials and Enrolment
Table 5: Europe – Country wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials and Enrolment
Table 7: North America – Country wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Neuromyelitis Optica (Devic’s Syndrome) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Neuromyelitis Optica (Devic’s Syndrome) Average Enrollment by Phase
Table 15: Neuromyelitis Optica (Devic’s Syndrome) Average Enrollment by Trial Status
Table 16: Neuromyelitis Optica (Devic’s Syndrome) Average Enrollment by Type
Table 17: Neuromyelitis Optica (Devic’s Syndrome)- Average Enrolment by Type of Sponsors
Table 18: Neuromyelitis Optica (Devic’s Syndrome)- Enrolment by Leading Sponsors